Non steroidal anti-inflammatory drug (NSAIDs) in breast cancer chemotherapy; antimony(V) salicylate a DNA binder

Abstract The organoantimony(V) derivative of salicylic acid (SalH2), {[Ph3Sb(SalH)]2O} (SalOSbi) was synthesized and tested for its anti-proliferative activity. SalOSbi was characterized by melting point and FT-IR, 1H NMR, Uv–Vis spectroscopic techniques. Its crystal and molecular structure is also determined by single-crystal X-ray diffraction crystallography. The antiproliferative activity of SalOSbi against human breast cancer cells: MCF-7 (Hormone Dependent (HD)) and MDA-MB-231 (Hormon Independent (HI) is congener or better than that of cisplatin. However SalOSbi is less toxic (by 7-fold) against human lung embryonic fibroblast cells (MRC-5), than cisplatin. Micronucleus assay shows that SalOSbi demonstrates similar in vitro genotoxicity with cisplatin against MRC-5 cells. The apoptotic type of cells death, caused by SalOSbi, was studied by cell cycle arrest and permeabilization of the mitochondrial membrane test. Electronic spectroscopic data confirm strong covalent binding of SalOSbi with DNA, through N(purine or pyrimidine)-M bonds in a similar manner to cisplatin. No inhibitory interaction with lipoxygenase (LOX) has been detected suggesting the non-involvement of the mitochondrial apoptotic pathway.

• Publication year

  2019

• Venue

  Inorganica Chimica Acta

• Publication date

  2019-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.ICA.2019.02.004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• New metalo-therapeutics of NSAIDs against human breast cancer cells.

  2018cited by this paper
• Nimesulide Silver Metallodrugs, Containing the Mitochondriotropic, Triaryl Derivatives of Pnictogen; Anticancer Activity against Human Breast Cancer Cells.

  2016cited by this paper
• New ways to boost molecular dynamics simulations

  2015cited by this paper
• Crystal structure refinement with SHELXL

  2015cited by this paper
• Novel mixed metal Ag(I)-Sb(III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant CTAB.

  2015cited by this paper
• Recent advances on antimony(III/V) compounds with potential activity against tumor cells.

  2015cited by this paper
• YASARA View—molecular graphics for all devices—from smartphones to workstations

  2014cited by this paper
• A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.

  2014cited by this paper
• Synthesis, crystal structure, and bioactivity of two triphenylantimony derivatives with benzohydroxamic acid and N-phenylbenzohydroxamic acid

  2012cited by this paper
• Genotoxicity of silver nanoparticles evaluated using the Ames test and in vitro micronucleus assay.

  2012cited by this paper
• Conformational analysis of triphenylphosphine in square planar organometallic complexes: [(PPh3)(ML1L2L3)] and [M(acac)(L')(PPh3)].

  2012cited by this paper
• Mixed ligand-silver(I) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis.

  2012cited by this paper
• Synthesis, characterization and biological studies of new antimony(III) halide complexes with ω-thiocaprolactam.

  2012cited by this paper
• Synthesis, structural characterization and biological studies of novel mixed ligand Ag(I) complexes with triphenylphosphine and aspirin or salicylic acid

  2011cited by this paper
• New delivery strategies for the old pentavalent antimonial drugs

  2010cited by this paper
• Biological Chemistry of Arsenic, Antimony and Bismuth

  2010cited by this paper
• Structural motifs and biological studies of new antimony(III) iodide complexes with thiones.

  2010cited by this paper
• New antimony(III) bromide complexes with thioamides: synthesis, characterization, and cytostatic properties.

  2009cited by this paper
• Synthesis, Characterization, and Biological Studies of Organotin(IV) Derivatives with o- or p-hydroxybenzoic Acids

  2009cited by this paper
• DNA-binding drugs caught in action: the latest 3D pictures of drug-DNA complexes.

  2009cited by this paper
• AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

  2009cited by this paper
• The micronucleus assay determination of chromosomal level DNA damage.

  2008cited by this paper
• A short history of SHELX.

  2008cited by this paper
• Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides.

  2008cited by this paper
• Biological studies of new organotin(IV) complexes of thioamide ligands.

  2008cited by this paper
• Perspectives of antimony compounds in oncology

  2008cited by this paper
• Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “sub‐G1” peaks on DNA content histograms

  2007cited by this paper
• Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes.

  2007cited by this paper
• Inflammation and cancer: the role of the immune response and angiogenesis.

  2006cited by this paper
• Comparison of multiple Amber force fields and development of improved protein backbone parameters

  2006cited by this paper
• Synthesis and characterization of new water stable antimony(III) complex with pyrimidine-2-thione and in vitro biological study

  2005cited by this paper
• Breast cancer: a review of the literature.

  2003cited by this paper
• Apoptosis: bombarding the mitochondria.

  2003cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.

  2002cited by this paper
• Novel Intracellular SbV Reducing Activity Correlates with Antimony Susceptibility in Leishmania donovani *

  2001cited by this paper
• Interaction of antimony tartrate with the tripeptide glutathione implication for its mode of action.

  2000cited by this paper
• Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.

  2000cited by this paper
• Molecular characterization of mitochondrial apoptosis-inducing factor

  1999cited by this paper
• Medicinal Inorganic Chemistry

  1999cited by this paper
• Structural code for DNA recognition revealed in crystal structures of papillomavirus E2-DNA targets.

  1998cited by this paper
• Cell cycle arrest, apoptosis and p53 expression in nickel(II) acetate-treated Chinese hamster ovary cells.

  1998cited by this paper
• Cancer statistics, 1997

  1997cited by this paper
• Crystal and molecular structure of cis-[Pt(NH3)2{d(pGpG)}], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA

  1988cited by this paper
• X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))].

  1985cited by this paper
• Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen–sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2′-yl)-2,6-dithiaheptane]copper(II) perchlorate

  1984cited by this paper

• Ni/Pd Dual-Catalysis Strategy for C(sp2)-Sb Cross-Coupling of Halostibines with Aryl Triflates and Applications of Products as Coupling Reagents, Ligands, and Anticancer Compounds.

  2025cites this paper
• Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: In vitro and in vivo studies

  2024cites this paper
• Nickel-Catalyzed C(sp3)-Sb Coupling of Chlorostibines with Unactivated Alkyl Chlorides and In Vitro Anticancer Activity of Products.

  2023cites this paper
• Mitochondriotropic agents conjugated with NSAIDs through metal ions against breast cancer cells.

  2023cites this paper
• Syntheses and characterization of novel antimony (III) and bismuth (III) derivatives containing β‐enamino ester along with antimicrobial evaluation, DFT calculation, and cytotoxic study

  2023cites this paper
• Synthesis and Structure of Tetraphenylstibonium Organosulfonates Ph_4SbOSO_2R, R = C_10H_15O, C_10H_4(OH-1)(NO_2)_2-2,4, C_10H_7-1, C_6H_4(COOH-2)

  2023cites this paper
• Possible implementation of salicylate anions in lead detoxification.

  2023cites this paper
• Oxidation of Tris(5-bromo-2-methoxyphenyl)antimony by tert-Butyl Hydroperoxide in the Presence of Compounds Containing an Active Hydrogen Atom

  2023cites this paper
• Synthesis of Triarylantimony(V) Compounds with Salicylic and Acetylsalicylic Acids

  2023cites this paper
• Molecular structure and photocatalytic properties of the pentaphenylantimony–3,5-dinitrosalicylic acid reaction product

  2022cites this paper
• Interactions of antimony with biomolecules and its effects on human health.

  2022cites this paper
• Conjugation of triphenylantimony(V) with carvacrol against human breast cancer cells

  2022cites this paper
• Characteristic Features of the Reactions of Triarylantimony with Hydroxybenzoic Acids. Structure of the Reaction Products

  2022cites this paper
• Conjugation of tetracycline and penicillin with Sb(v) and Ag(i) against breast cancer cells

  2022cites this paper
• Synthesis and Structure of Tetra(para-tolyl)antimony Carboxylates p-Tol4SbOC(O)R (R = C6H3F2-2,3, C6H3F2-3,4, C6H3F2-2,5)

  2022cites this paper
• Reactions of Benzenesulfonic Acid with Certain Tolyl Derivatives of Antimony

  2022cites this paper
• Metal complexes of NSAIDs as potent anti-tumor chemotherapeutics: Mechanistic insights into cytotoxic activity via multiple pathways primarily by inhibition of COX–1 and COX–2 enzymes

  2021cites this paper
• Novel silver glycinate conjugate with 3D polymeric intermolecular self-assembly architecture; an antiproliferative agent which induces apoptosis on human breast cancer cells.

  2021cites this paper
• A Mini Review of Drug-Metal Compounds in Cancer Treatment

  2021cites this paper
• Arsenic, Antimony and Bismuth

  2021cites this paper
• Evaluation of Toxicity with Brine Shrimp Assay.

  2021cites this paper
• Tris(fluorophenyl)antimony Dicarboxylates (4-FC6H4)3Sb[OC(O)R]2 (R = CH2Cl, C6F5, C6F4H-2, CF2CF3, CF2CF2CF3) and (3-FC6H4)3Sb[OC(O)C6F4H-2]2: Synthesis and Structure

  2020cites this paper
• Aryl Compounds of Pentavalent Antimony: Syntheses, Reactions, and Structures

  2020cites this paper
• Strontium and antimony serum levels in healthy individuals living in high‐ and low‐risk areas of esophageal cancer

  2020cites this paper
• Specific Features of the Reactions of Pentaphenylantimony with Polyfunctional Heterocyclic Carboxylic Acids

  2020cites this paper
• Manganese(II) coordination compounds of carboxylate non-steroidal anti-inflammatory drugs.

  2019cites this paper
• Antiproliferative activity and apoptosis induction, of organo-antimony(III)–copper(I) conjugates, against human breast cancer cells

  2019cites this paper